Koers China Grand Pha.and Healthcare Hld. Ltd. Hong Kong S.E.
Aandelen
0512
BMG210A71198
Farmaceutische producten
Omzet 2024 * | 11,95 mld. 1,53 mld. 1,43 mld. | Omzet 2025 * | 13,58 mld. 1,74 mld. 1,62 mld. | Marktkapitalisatie | 16,6 mld. 2,13 mld. 1,98 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 2,23 mld. 285 mln. 266 mln. | Nettowinst (verlies) 2025 * | 2,54 mld. 325 mln. 304 mln. | EV/omzet 2024 * | 1,39 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,22 x |
K/w-verhouding 2024 * |
7,52
x | K/w-verhouding 2025 * |
6,58
x | Werknemers | - |
Dividendrendement 2024 * |
6,54% | Dividendrendement 2025 * |
6,12% | Vrij verhandelbaar | 28,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 34 | 01-04-19 |
Tin Chung Foo
SEC | Corporate Secretary | 56 | 01-09-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 61 | 21-03-05 |
Ye Bi Hu
BRD | Director/Board Member | 60 | 31-12-18 |
Geng Pei
BRD | Director/Board Member | 64 | 12-05-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,19% | 801 mld. | |
+47,26% | 631 mld. | |
-6,09% | 359 mld. | |
+21,92% | 337 mld. | |
+18,40% | 245 mld. | |
+3,64% | 231 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 161 mld. |